Cargando…

New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function

Schizophrenia is considered a neurodevelopmental and neurodegenerative disorder. Cognitive impairment is a core symptom in patients with the illness, and has been suggested a major predictor of functional outcomes. Reduction of parvalbumin (PV)-positive γ-aminobutyric acid (GABA) interneurons has be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeon, Won Je, Sumiyoshi, Tomiki, Kurachi, Masayoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759318/ https://www.ncbi.nlm.nih.gov/pubmed/26630957 http://dx.doi.org/10.2174/1570159X13666151009120153

Ejemplares similares

Early Intervention and a Direction of Novel Therapeutics for the Improvement of Functional Outcomes in Schizophrenia: A Selective Review
por: Kurachi, Masayoshi, et al.
Publicado: (2018)

T-817MA, but Not Haloperidol and Risperidone, Restores Parvalbumin-Positive γ-Aminobutyric Acid Neurons in the Prefrontal Cortex and Hippocampus of Rats Transiently Exposed to MK-801 at the Neonatal Period
por: Uehara, Takashi, et al.
Publicado: (2012)

GABA Neuron Alterations, Cortical Circuit Dysfunction and Cognitive Deficits in Schizophrenia
por: Gonzalez-Burgos, Guillermo, et al.
Publicado: (2011)

Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2014)

Cognitive Deficits in Schizophrenia and Other Neuropsychiatric Disorders: Convergence of Preclinical and Clinical Evidence
por: Stuchlik, Ales, et al.
Publicado: (2014)

Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013)

Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2019)

Psychoneurobiology Research and Personalized Treatment of Schizophrenia
por: Sumiyoshi, Tomiki
Publicado: (2021)

Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs
por: Ohi, Kazutaka, et al.
Publicado: (2018)

Apocynin-Tandospirone Derivatives Suppress Methamphetamine-Induced Hyperlocomotion in Rats with Neonatal Exposure to Dizocilpine
por: Uehara, Takashi, et al.
Publicado: (2022)

Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
por: Vecera, Courtney M., et al.
Publicado: (2023)

Electrophysiological Evidence in Schizophrenia in Relation to Treatment Response
por: Sueyoshi, Kazuki, et al.
Publicado: (2018)

Does Sleep Improve Memory Organization?
por: Takeuchi, Masashi, et al.
Publicado: (2014)

Limitations of Current GABA Agonists in Neonatal Seizures: Toward GABA Modulation Via the Targeting of Neuronal Cl(−) Transport
por: Khanna, Arjun, et al.
Publicado: (2013)

Neural Correlates for Intrinsic Motivational Deficits of Schizophrenia; Implications for Therapeutics of Cognitive Impairment
por: Takeda, Kazuyoshi, et al.
Publicado: (2018)

Positive symptoms and time perception in schizophrenia: A meta-analysis
por: Ueda, Natsuki, et al.
Publicado: (2018)

Emerging pharmacotherapy for cancer patients with cognitive dysfunction
por: Davis, Justin, et al.
Publicado: (2013)

The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia
por: Cotter, Jack, et al.
Publicado: (2019)

Editorial: Cognitive Enhancement in Psychiatric Disorders
por: Sumiyoshi, Tomiki, et al.
Publicado: (2019)

Tandospirone, a 5-HT(1A) partial agonist, ameliorates aberrant lactate production in the prefrontal cortex of rats exposed to blockade of N-methy-D-aspartate receptors; Toward the therapeutics of cognitive impairment of schizophrenia
por: Uehara, Takashi, et al.
Publicado: (2014)

Associations between daily living skills, cognition, and real-world functioning across stages of schizophrenia; a study with the Schizophrenia Cognition Rating Scale Japanese version
por: Higuchi, Yuko, et al.
Publicado: (2017)

Electrophysiological and Neuropsychological Predictors of Conversion to Schizophrenia in At-Risk Subjects
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013)

Specificity and Continuity of Schizophrenia and Bipolar Disorder: Relation to  Biomarkers
por: Yamada, Yuji, et al.
Publicado: (2020)

In silico hippocampal modeling for multi-target pharmacotherapy in schizophrenia
por: Sherif, Mohamed A., et al.
Publicado: (2020)

Sex Differences in Social Cognition and Association of Social Cognition and Neurocognition in Early Course Schizophrenia
por: Kubota, Ryotaro, et al.
Publicado: (2022)

Effect of 5-HT(1A) Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
por: Yamada, Risa, et al.
Publicado: (2023)

Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
por: Omachi, Yoshie, et al.
Publicado: (2018)

Pharmacotherapy for treatment-resistant schizophrenia
por: Mcilwain, Meghan E, et al.
Publicado: (2011)

Semantic Memory Organization in Japanese Patients With Schizophrenia Examined With Category Fluency
por: Sumiyoshi, Chika, et al.
Publicado: (2018)

Transcranial Direct Current Stimulation on the Left Superior Temporal Sulcus Improves Social Cognition in Schizophrenia: An Open-Label Study
por: Yamada, Yuji, et al.
Publicado: (2022)

Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase
por: KIRLI, Umut, et al.
Publicado: (2021)

Adjunctive antidepressive pharmacotherapy in schizophrenia patients
por: Zink, M.
Publicado: (2021)

A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia
por: Ohi, Kazutaka, et al.
Publicado: (2019)

LORETA Current Source Density for Duration Mismatch Negativity and Neuropsychological Assessment in Early Schizophrenia
por: Miyanishi, Tomohiro, et al.
Publicado: (2013)

Selective Activation of Cholecystokinin-Expressing GABA (CCK-GABA) Neurons Enhances Memory and Cognition
por: Whissell, Paul D., et al.
Publicado: (2019)

S239. PREDICTIVE ACCURACY FOR WORK OUTCOME IN PATIENTS WITH SCHIZOPHRENIA
por: Sumiyoshi, Chika, et al.
Publicado: (2018)

Research in pharmacotherapy for erectile dysfunction
por: Ryu, Ji-Kan, et al.
Publicado: (2017)

A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient
por: Ohi, Kazutaka, et al.
Publicado: (2017)

Perceptual inference, accuracy, and precision in temporal reproduction in schizophrenia
por: Ueda, Natsuki, et al.
Publicado: (2021)

Predicting employment status and subjective quality of life in patients with schizophrenia
por: Fujino, Haruo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uv845gngfcldop0pmu4jh9tvnr